首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Kallikrein rK10-induced kinin-independent direct activation of NO-formation and relaxation of rat isolated aortic rings.
【2h】

Kallikrein rK10-induced kinin-independent direct activation of NO-formation and relaxation of rat isolated aortic rings.

机译:激肽释放酶rK10诱导的激肽独立NO形成的直接激活和大鼠离体主动脉环的松弛。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. rK10, a weak T-kininogenase isolated from the rat submandibular gland, is a protein belonging to the rat kallikrein family. In the present work, we have studied the biological effects of rK10 with respect to its ability to alter vascular resistance, either directly like rK9, i.e. another kallikrein-like protein, trypsin and thrombin, or through the release of kinins like tissue kallikrein (rK1). The direct effect was studied by its vasomotor activity on rat isolated aortic rings since this preparation was insensitive to the action of kinins. Its ability to induce altered vascular resistance through kinin-generation was investigated by blood pressure studies in whole animals. The studies were performed in comparison to rK1. 2. Unlike rK1, which induces hypotension when administered intravenously to rats (delta BP = -56 +/- 5 mmHg, 5 micrograms kg-1), rK10 did not have any effect on systemic blood pressure (delta BP = -3 +/- 1, 5 micrograms kg-1, i.v.). 3. rK10 was without effect on uncontracted aortic rings, but showed a concentration-dependent (10(-8)-10(-6) M) relaxant effect on tissue precontracted with phenylephrine (10(-6) M). After removal of endothelial cells, no relaxation was observed. The relaxant response to rK10 was transient. rK1 (with and without endothelium), bradykinin and T-kinin (with endothelium) had no effect on contracted or uncontracted aortic rings. 4. The relaxant effect of rK10 was dependent on its enzymatic activity since preincubation with aprotinin (1.02 mM) significantly reduced vasorelaxation from 74 +/- 4% to 24 +/- 3%.(ABSTRACT TRUNCATED AT 250 WORDS)
机译:1. rK10是一种从大鼠下颌下腺分离的弱T激肽原酶,是一种属于大鼠激肽释放酶家族的蛋白。在目前的工作中,我们已经研究了rK10改变其血管阻力的生物学效应,可以直接像rK9,即另一种激肽释放酶样蛋白,胰蛋白酶和凝血酶,或者通过释放激肽如组织激肽释放酶(rK1 )。由于其对大鼠离体主动脉环的血管舒缩活性而研究了直接作用,因为该制剂对激肽的作用不敏感。通过对整个动物的血压研究,研究了其通过激肽生成诱导血管阻力改变的能力。与rK1比较进行了研究。 2.与rK1不同,rK1在静脉内给予大鼠时会引起低血压(δBP = -56 +/- 5 mmHg,5微克kg-1),rK10对全身血压没有任何影响(δBP = -3 + / -1、5微克kg-1,iv)。 3. rK10对未收缩的主动脉环无影响,但对以苯肾上腺素(10(-6)M)预收缩的组织表现出浓度依赖性(10(-8)-10(-6)M)的松弛作用。去除内皮细胞后,未观察到松弛。对rK10的松弛反应是短暂的。 rK1(带和不带内皮),缓激肽和T-激肽(带内皮)对收缩或未收缩的主动脉环均无影响。 4. rK10的松弛作用取决于其酶促活性,因为与抑肽酶(1.02 mM)的预温育可将血管松弛从74 +/- 4%显着降低至24 +/- 3%。(摘要截短为250字)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号